Amyotrophic Lateral Sclerosis Treatment Market Size, Share & Growth Report 2032
Amyotrophic Lateral Sclerosis Treatment Market By Treatment (Stem Cell Therapy, Medication, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 832.97 Million | USD 1470.65 Million | 6.52% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Amyotrophic Lateral Sclerosis Treatment Market, 2024-2032 (USD Million)
- 2.2. Amyotrophic Lateral Sclerosis Treatment Market: Snapshot
- Chapter 3. Amyotrophic Lateral Sclerosis Treatment Market - Industry Analysis
- 3.1. Amyotrophic Lateral Sclerosis Treatment Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Increasing geriatric population worldwide
- 3.2.2. Rising awareness regarding ALS
- 3.3. Restraints
- 3.3.1. High cost of ALS treatment
- 3.3.2. Lack of skilled medical professionals
- 3.4. Opportunity
- 3.4.1. Technological advancements
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis By Treatment
- 3.6.2. Market attractiveness analysis By Distribution Channel
- 3.6.3. Market attractiveness analysis by Region
- Chapter 4. Amyotrophic Lateral Sclerosis Treatment Market- Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Amyotrophic Lateral Sclerosis Treatment Market: company market share, 2024
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Treatment launches
- 4.2.3. Agreements, partnerships, collaborations and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Amyotrophic Lateral Sclerosis Treatment Market -Treatment Analysis
- 5.1. Global Amyotrophic Lateral Sclerosis Treatment Market overview: By Treatment type
- 5.1.1. Global Amyotrophic Lateral Sclerosis Treatment Market share, By Treatment,2024 and 2032
- 5.2. Stem Cell Therapy
- 5.2.1. Global Amyotrophic Lateral Sclerosis Treatment Market by Stem Cell Therapy, 2024-2032 (USD Million)
- 5.3. Medication
- 5.3.1. Global Amyotrophic Lateral Sclerosis Treatment Market by Medication, 2024-2032 (USD Million)
- 5.4. Others
- 5.4.1. Global Amyotrophic Lateral Sclerosis Treatment Market by Others, 2024-2032 (USD Million)
- 5.1. Global Amyotrophic Lateral Sclerosis Treatment Market overview: By Treatment type
- Chapter 6. Global Amyotrophic Lateral Sclerosis Treatment Market -Distribution Channel Analysis
- 6.1. Global Amyotrophic Lateral Sclerosis Treatment Market overview: By Distribution Channel
- 6.1.1. Global Amyotrophic Lateral Sclerosis Treatment Market share, By Distribution Channel, 2024 and 2032
- 6.2. Retail Pharmacies
- 6.2.1. Global Amyotrophic Lateral Sclerosis Treatment Market by Retail Pharmacies, 2024-2032 (USD Million)
- 6.3. Hospital Pharmacies
- 6.3.1. Global Amyotrophic Lateral Sclerosis Treatment Market by Hospital Pharmacies, 2024-2032 (USD Million)
- 6.4. Others
- 6.4.1. Global Amyotrophic Lateral Sclerosis Treatment Market by Others, 2024-2032 (USD Million)
- 6.1. Global Amyotrophic Lateral Sclerosis Treatment Market overview: By Distribution Channel
- Chapter 7. Global Amyotrophic Lateral Sclerosis Treatment Market - Regional Analysis
- 7.1. Global Amyotrophic Lateral Sclerosis Treatment Market overview: by Region
- 7.1.1. Global Amyotrophic Lateral Sclerosis Treatment Market share, by Region, 2024 and 2032
- 7.2. North America
- 7.2.1. North America Amyotrophic Lateral Sclerosis Treatment Market, 2024-2032 (USD Million)
- 7.2.2. North America Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.2.3. North America Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.2.4. The U.S.
- 7.2.4.1. The U.S. Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.2.4.2. The U.S. Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.2.5. Rest of North America
- 7.2.5.1. Rest of North America Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.2.5.2. Rest of North America Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Amyotrophic Lateral Sclerosis Treatment Market, 2024-2032 (USD Million)
- 7.3.2. Europe Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.3.3. Europe Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.3.4. UK
- 7.3.4.1. U.K. Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.3.4.2. U.K. Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.3.5. France
- 7.3.5.1. France Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.3.5.2. France Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.3.6. Germany
- 7.3.6.1. Germany Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.3.6.2. Germany Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.3.7. Rest of Europe
- 7.3.7.1. Rest of Europe Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.3.7.2. Rest of Europe Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market, 2024-2032 (USD Million)
- 7.4.2. Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.4.3. Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.4.4. China
- 7.4.4.1. China Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.4.4.2. China Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.4.5. Japan
- 7.4.5.1. Japan Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.4.5.2. Japan Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.4.6. India
- 7.4.6.1. India Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.4.6.2. India Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.4.7. Rest of Asia Pacific
- 7.4.7.1. Rest of Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.4.7.2. Rest of Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Amyotrophic Lateral Sclerosis Treatment Market, 2024-2032 (USD Million)
- 7.5.2. Latin America Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.5.3. Latin America Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.5.4. Brazil
- 7.5.4.1. Brazil Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.5.4.2. Brazil Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.5.5. Rest of Latin America
- 7.5.5.1. Rest of Latin America Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.5.5.2. Rest of Latin America Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.6. The Middle East and Africa
- 7.6.1. The Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Market, 2024-2032 (USD Million)
- 7.6.2. The Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Market revenue, By Treatment,2024-2032 (USD Million)
- 7.6.3. The Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Market revenue, By Distribution Channel, 2024-2032 (USD Million)
- 7.1. Global Amyotrophic Lateral Sclerosis Treatment Market overview: by Region
- Chapter 8. Company Profiles
- 8.1. Otsuka Pharmaceutical Co., Ltd.
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Treatment Portfolio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Otsuka Pharmaceutical Co., Ltd.
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Treatment Portfolio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. BrainStorm Therapeutics
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Treatment Portfolio
- 8.3.4. Business Strategy
- 8.3.5. Recent Developments
- 8.4. AB Science
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Treatment Portfolio
- 8.4.4. Business Strategy
- 8.4.5. Recent Developments
- 8.5. Biogen Inc.
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Treatment Portfolio
- 8.5.4. Business Strategy
- 8.5.5. Recent Development
- 8.6. F.Hoffmann-La Roche AG
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Treatment Portfolio
- 8.6.4. Business Strategy
- 8.6.5. Recent Development
- 8.7. Corestem
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Treatment Portfolio
- 8.7.4. Business Strategy
- 8.7.5. Recent Development
- 8.8. Biohaven Pharmaceutical
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Treatment Portfolio
- 8.8.4. Business Strategy
- 8.8.5. Recent Development
- 8.9. AB Science
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Treatment Portfolio
- 8.9.4. Business Strategy
- 8.9.5. Recent Development
- 8.10. Ionis Pharmaceuticals, Inc.
- 8.10.1. Overview
- 8.10.2. Financials
- 8.10.3. Treatment Portfolio
- 8.10.4. Business Strategy
- 8.10.5. Recent Development
- 8.11. Sun Pharmaceutical
- 8.11.1. Overview
- 8.11.2. Financials
- 8.11.3. Treatment Portfolio
- 8.11.4. Business Strategy
- 8.11.5. Recent Development
- 8.1. Otsuka Pharmaceutical Co., Ltd.
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Amyotrophic Lateral Sclerosis Treatment, 2024–2032 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Amyotrophic Lateral Sclerosis Treatment attractiveness, By Treatment type
6. Global Amyotrophic Lateral Sclerosis Treatment attractiveness, By Distribution Channel
7. Global Amyotrophic Lateral Sclerosis Treatment market share, By Treatment, 2024 and 2032
8. Global Amyotrophic Lateral Sclerosis Treatment by Stem Cell Therapy, 2024–2032 (USD Million)
9. Global Amyotrophic Lateral Sclerosis Treatment by Medication,2024–2032 (USD Million)
10. Global Amyotrophic Lateral Sclerosis Treatment by Others,2024–2032 (USD Million)
11. Global Amyotrophic Lateral Sclerosis Treatment share, By Distribution Channel, 2024 and 2032
12. Global Amyotrophic Lateral Sclerosis Treatment by Retail Pharmacies, 2024–2032 (USD Million)
13. Global Amyotrophic Lateral Sclerosis Treatment by Hospital Pharmacies, 2024–2032 (USD Million)
14. Global Amyotrophic Lateral Sclerosis Treatment by Others, 2024–2032 (USD Million)
15. Global Amyotrophic Lateral Sclerosis Treatment share, by Region, 2024and 2032
16. North America Amyotrophic Lateral Sclerosis Treatment, 2024–2032 (USD Million)
17. Europe Amyotrophic Lateral Sclerosis Treatment, 2024–2032 (USD Million)
18. Asia Pacific Amyotrophic Lateral Sclerosis Treatment, 2024–2032 (USD Million)
19. Latin America Amyotrophic Lateral Sclerosis Treatment, 2024–2032 (USD Million)
20. The Middle East and Africa Amyotrophic Lateral Sclerosis Treatment, 2024–2032 (USD Million)
Table Of Tables
List of Tables
1. Global Amyotrophic Lateral Sclerosis Treatment: snapshot
2. Drivers of the Amyotrophic Lateral Sclerosis Treatment: impact analysis
3. Restraints of the Amyotrophic Lateral Sclerosis Treatment: impact analysis
4. North America Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
5. North America Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
6. The U.S. Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
7. The U.S. Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
8. Rest of North America Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
9. Rest of North America Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
10. Europe Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
11. Europe Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
12. U.K. Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
13. U.K. Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
14. France Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
15. France Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
16. Germany Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
17. Germany Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
18. Rest of Europe Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
19. Rest of Europe Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
20. Asia Pacific Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
21. Asia Pacific Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
22. China Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
23. China Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
24. Japan Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
25. Japan Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
26. India Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
27. India Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
28. Rest of Asia Pacific Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
29. Rest of Asia Pacific Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
30. Latin America Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
31. Latin America Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
32. Brazil Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
33. Brazil Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
34. Rest of Latin America Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
35. Rest of Latin America Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
36. The Middle East and Africa Amyotrophic Lateral Sclerosis Treatment revenue, By Treatment,2024–2032 (USD Million)
37. The Middle East and Africa Amyotrophic Lateral Sclerosis Treatment revenue, By Distribution Channel, 2024–2032 (USD Million)
Methodology
FrequentlyAsked Questions
Amyotrophic Lateral Sclerosis (ALS) treatment focuses primarily on managing symptoms and slowing disease progression, as there's currently no cure.
According to a study, the global amyotrophic lateral sclerosis treatment market size was worth around USD 832.97 million in 2023 and is expected to reach USD 1470.65 million by 2032.
The global amyotrophic lateral sclerosis treatment market is expected to grow at a CAGR of 6.52% during the forecast period.
North America is expected to dominate the amyotrophic lateral sclerosis treatment market over the forecast period.
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed